In the coming years, North America is poised to maintain its prominent position as a key player in the Non-Small Cell Lung Carcinoma NSCLC Industry, solidifying its status as one of the most lucrative regions. This dominance is underpinned by the region’s robust pipeline and extensive research endeavors by both industry stakeholders and academic institutions. …
Tag Archives: Non-Small Cell Lung Carcinoma (NSCLC) Market
Non-Small Cell Lung Carcinoma (NSCLC) Market Set to Reach US$21.40 Billion by 2033, Fueled by 10% CAGR
The global Non-Small Cell Lung Carcinoma (NSCLC) Market is predicted to generate a market value of US$ 8.25 billion in 2023 and a market value of US$ 21.40 billion by 2023-2033, at a CAGR of 10%. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Non-Small Cell Lung …